Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
Published Online: 2025-11-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Alexander Stein•Anna C Virgili•Anwaar Saeed•Cathy Eng•Cixin Steven He•Elisa Fontana•Gholamreza Asghari•Guan Wang•J Randolph Hecht•Jane So•Josep Tabernero•Lubomir Bodnar•Marc Van den Eynde•Marwan Fakih•Myung-Ah Lee•Olivier Dubreuil•Robina Smith•Soohyeon Lee•Young Suk Park
